<?xml version="1.0" encoding="UTF-8"?>
<p class="p">According to a WHO commission report (Organization 2007) evaluating the safety of kava products special water-based preparation should be preferred over extracts obtained by organic solvents. In addition, more studies are needed for the developments of standardized aqueous extracts which should be validated by well-designed controlled clinical trials.</p>
